NASDAQ · SGHT
Sight Sciences, Inc.
$9.57+$0.33 (+3.57%)
Sight Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
Loading market information…
NASDAQ · INGN · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Inogen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Inogen, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of -$0.11. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Inogen, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 7, 2025 |
| -$0.25+51.92% vs estimate |
| $82.28M-11.27% vs estimate |
| Q4 2024 | Feb 25, 2025 | -$0.41+26.79% vs estimate | $80.08M+8.36% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | -$0.25+48.98% vs estimate | $88.83M+20.21% vs estimate |
|---|
THE ANALYST VIEW
11 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$9.57+$0.33 (+3.57%)
Sight Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
$7.25-$0.13 (-1.76%)
Eupraxia Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.21% below the high.
$20.44+$0.96 (+4.93%)
Shoulder Innovations, Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.91% below the high.
$3.15+$0.03 (+0.8%)
Quanterix Corporation’s quoted price sits in the lower half of its reported 52-week range, 64.14% below the high.
$1.79-$0.01 (-0.56%)
Health Catalyst, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
$1.17-$0.08 (-6.02%)
Perspective Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.01% below the high.
$2.26-$0.03 (-1.31%)
Solana Company’s quoted price sits in the lower half of its reported 52-week range, 66.27% below the high.
$4.19-$0.15 (-3.46%)
Outset Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.71% below the high.
